» Articles » PMID: 27186187

Predictors of Deterioration of Lung Function in Polish Children with Cystic Fibrosis

Overview
Journal Arch Med Sci
Specialty General Medicine
Date 2016 May 18
PMID 27186187
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Severity of lung disease varies in patients with the same CFTR genotype. It suggests that other factors affect the severity of cystic fibrosis (CF). The aim of the study was to identify risk factors that determine lung function decline in Polish cystic fibrosis children.

Material And Methods: The follow-up time was no less than 5 years of respiratory status observation based on the forced expiratory volume in 1 s value (FEV1). The socio-economic data, perinatal interview, presence of meconium ileus (MI), time of CF diagnosis, initiation of tobramycin inhalation solution (TIS), pancreatic function, sensitization to Aspergillus fumigatus, presence of impaired glucose tolerance (IGT) or diabetes mellitus, chronic bacterial colonization and number of exacerbations and hospitalizations were assessed.

Results: The mean age of 61 included children was 13.3 ±7.6 years. Delta F508 homozygosity was detected in 45.9%, 44.3% were delta F508 heterozygous, and 9.8% had other genotypes. FEV1 decline was observed among 20% of patients; the rest of the patients presented stable values of FEV1 during at least 5 years of observation. The most significant predictors related to the decline of FEV1 were presentation of MI (p = 0.0344), IGT (p = 0.0227), number of exacerbations (p = 0.0288), and early Pseudomonas aeruginosa (PA) chronic colonization (p = 0.0165) followed by late TIS initiation after the first detection of PA (p=0.0071). Neither time of diagnosis nor type of CFTR mutation was statistically significant as a predictor of lung deterioration.

Conclusions: The presence of MI, IGT, chronic PA colonization, and number of exacerbations are risk factors for lung function deterioration.

Citing Articles

The influence of erythropoietin on apoptosis and fibrosis in the early phase of chronic pancreatitis in rats.

Kazmierak W, Korolczuk A, Kurzepa J, Czechowska G, Boguszewska-Czubara A, Madro A Arch Med Sci. 2021; 17(4):1100-1108.

PMID: 34336038 PMC: 8314426. DOI: 10.5114/aoms.2020.99800.


Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED).

Mozzillo E, Franceschi R, Piona C, Passanisi S, Casertano A, Pjetraj D Front Endocrinol (Lausanne). 2021; 12:673539.

PMID: 34017312 PMC: 8130616. DOI: 10.3389/fendo.2021.673539.


Preliminary national report on cystic fibrosis epidemiology in Tunisia: the actual state of affairs.

Hamouda S, Hadj Fredj S, Hilioui S, Khalsi F, Ameur S, Bouguila J Afr Health Sci. 2021; 20(1):444-452.

PMID: 33402933 PMC: 7750075. DOI: 10.4314/ahs.v20i1.51.


Body composition and lung function in children with cystic fibrosis and meconium ileus.

Doulgeraki A, Petrocheilou A, Petrocheilou G, Chrousos G, Doudounakis S, Kaditis A Eur J Pediatr. 2017; 176(6):737-743.

PMID: 28409283 DOI: 10.1007/s00431-017-2906-z.

References
1.
Debska G, Mazurek H . Factors related to changes in the quality of life among Polish adolescents and adults with cystic fibrosis over a 1-year period. Patient Prefer Adherence. 2016; 9:1763-70. PMC: 4689266. DOI: 10.2147/PPA.S88385. View

2.
Ooi C, Durie P . Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis. J Cyst Fibros. 2012; 11(5):355-62. DOI: 10.1016/j.jcf.2012.05.001. View

3.
Lavie M, Manovitz T, Vilozni D, Levy-Mendelovich S, Sarouk I, Weintraubv I . Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis. World J Gastroenterol. 2015; 21(1):318-25. PMC: 4284351. DOI: 10.3748/wjg.v21.i1.318. View

4.
Sawicki G, Signorovitch J, Zhang J, Latremouille-Viau D, von Wartburg M, Wu E . Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution. Pediatr Pulmonol. 2011; 47(1):44-52. DOI: 10.1002/ppul.21521. View

5.
Hameed S, Jaffe A, Verge C . Advances in the detection and management of cystic fibrosis related diabetes. Curr Opin Pediatr. 2015; 27(4):525-33. DOI: 10.1097/MOP.0000000000000251. View